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Snail1, snai1The speciﬁc program that enables the stereotypic differentiation of specialized cartilages, including the tra-
chea, is intrinsically distinct from the program that gives rise to growth plate hypertrophic chondrocytes.
For example, Snail1 is an effector of FGF signaling in growth plate pre-hypertrophic chondrocytes, but it de-
rails the normal program of permanent chondrocytes, repressing the transcription of Aggrecan and Collagen
type 2a1 (Col2a1). Here we show that miRNA activity is essential for normal trachea development and that
miR-125b and miR-30a/c keep Snail1 at low levels, thus enabling full functional differentiation of Col2a1 tra-
cheal chondrocytes. Speciﬁc inhibition of miR-125b and miR-30a/c in chondrocytes or Dicer1 knockout in the
trachea, de-repress Snail1. As a consequence, the transcription of Aggrecan and Col2a1 is hampered and ex-
tracellular matrix deposition is decreased. Our data reveals a new miRNA pathway that is safekeeping the
speciﬁc genetic program of differentiated and matrix-producing tracheal chondrocytes from acquisition of
unwanted signals. This pathway may improve understanding of human primary tracheomalacia and improve
protocols for cartilage tissue engineering.ornstein).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
microRNA (miRNA) are genome-encoded small RNAs, which regulate
gene expression posttranscriptionally (Bartel, 2009).miRNAs hairpin pre-
cursors are processed by the RNase III enzymes Drosha and Dicer1,
generating a single-stranded ~22nt miRNA, which programs the RNA-
induced silencing complex to repress speciﬁc targets. Recent evidence
indicates that miRNAs have a role in regulating the development and
maintenance of skeletal tissues (Hassan et al., 2010; Kobayashi et al.,
2008; Lin et al., 2009; Liu, 2009). Furthermore, several miRNA genes,
such as miR-140, miR-675, miR-145 and miR-199, appear to be highly
relevant to cartilage biology in culture and in vivo (Dudek et al., 2010;
Eberhart et al., 2008; Lin et al., 2009; Miyaki et al., 2010; Nicolas et al.,
2008; Tuddenham et al., 2006;Watanabe et al., 2008; Yang et al., 2011).
The transcription factor Sox9 is the principle activator of the
chondrocyte-speciﬁc differentiation program (Bell et al., 1997; Bi et
al., 1999), whereby it cooperatively functions with L-Sox5 and Sox6
(Lefebvre et al., 1998). Together, these Sox-family factors induce the ex-
pression of many effector genes and directly regulate the transcription
of extracellular matrix (ECM) proteins such as Col2a1 and Aggrecan.
The trachea is composed of C-shaped hyaline ‘rings’ that develop in
the mesenchyme surrounding the upper respiratory tract. Thestructural rigidity of the tracheal semi-lunar ‘rings’ prevents the airway
from collapsing during respiration. Several genetic pathways have been
shown to affect tracheal cartilage development, including hedgehog
(Miller et al., 2004), retinoic acid signaling (Mendelsohn et al., 1994;
Vermot et al., 2003) and ﬁbroblast growth factor (FGF) (Eswarakumar
et al., 2004; Sala et al., 2011). If signaling in any of these pathways
goes awry, a structurally weak trachea develops, giving rise to poten-
tially fatal airway collapse during respiration. This pathology is known
as primary tracheomalacia (for reviews see (Boogaard et al., 2005;
Carden et al., 2005; McNamara and Crabbe, 2004)).
FGF signaling plays multiple essential roles in growth plate
chondrogenesis (reviewed in (Ornitz and Marie, 2002)) and in the
trachea, yet its ectopic activation in the trachea results in poor depo-
sition of extracellular matrix (Eswarakumar et al., 2004; Sala et al.,
2011). Snail1 (also known as Snai1) is an important transcription
factor downstream of the FGF receptor in pre-hypertrophic chondro-
cytes, where it inhibits proliferation and represses Col2a1 and
Aggrecan expression, through interactions with HDAC1 and HDAC2
(de Frutos et al., 2007; Hong et al., 2009; Seki et al., 2003).
However, Snail1 is expressed at low levels in the tracheal cartilage,
suggesting that there is an idiosyncratic program for the differentia-
tion of this tracheal cartilage that deviates from related chondro-
genic program.
Our current analysis suggests that miRNA function in the trachea is
essential for proper synthesis and deposition of extracellular matrix.
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whose unwanted activity is harmful for the development of normal tra-
ceal cartilage. miR-30a/c and miR-125b function as direct repressors of
Snail1 expression and their speciﬁc downregulation in culture or in a
Dicer1 model in vivo, results in Snail1 upregulation, inhibited prolifera-
tion and perturbed expression of ECM proteins Col2a1 and Aggrecan.
Materials and methods
Mouse genetics
Dicer1 conditional allele, the gift of Mike McManus, Brian Harfe and
Cliff Tabin (Harfe et al., 2005), was PCR genotyped with primers: 5′-
CCTGACAGTGACGGTCCAAAG-3′ & 5′-CATGACTCTTCAACTCAAACT-3′.
The Col2a1-Cre was genotyped as in Amarilio et al. (2007). Mutant
Col2a1-Cre;Dicer1ﬂx/ﬂx;R26R(YFP) and Col2a1-Cre;Dicer1ﬂx/+;R26R
(YFP) littermate heterozygous controls were maintained in accordance
with the Weizmann Institute of Science IACUC guidelines. The day of
the vaginal plug appearance was considered embryonic day 0.5 (E0.5).
Histological studies and RNA in situ hybridization
Alcian blue/Alizarin red staining of E17.5-P1 trachea orwholemount
was performed as in Amarilio et al. (2007). For histology, the whole
respiratory tree, including the trachea and lungs was ﬁxed in 4%
paraformaldehyde-PBS (weight/vol.) over-night at 4 °C, dehydrated
into 100% ethanol, embedded in parafﬁn blocks and sectioned. E18.5
cell proliferation was assayed by a two-hour, 5-bromodeoxyuridine
pulse (BrdU, 30 mg/kg, I.P.). The fraction of BrdU-positive nuclei in tra-
cheal chondrocytes, was studied with cell proliferation kit (GE Health-
care). Quantiﬁcation of cells undergoing apoptosis in the trachea was
performed with a TUNEL detection kit (Roche). Parafﬁn section in-situ
hybridization was performed as in Brent et al. (2003) with antisense
probes corresponding to an intronic fragment of the mouse Snail1
(1004nt–1553nt; GenBank accession code NT 039210, the kind gift of
Olivier Pourquié) ormurine Sox9, Col2a1 and Aggrecan (as in (Amarilio
et al., 2007)).
Expression analysis by arrays and real-time PCR
Tracheal cartilage rings of E18.5 embryos were manually dissected
and incubated in Trypsin-EDTA (Bioind);37 °C;30′, twice (see Fig S3).
Total RNA was extracted with TRI Reagent (MRC). qPCR, performed in
technical triplicates on a LightCycler480 (Roche) using DyNAmo HS
SYBRGreen (Finnzyme) formRNAormiScript SYBRGreen PCR (Qiagen)
for miRNA. mRNA expression was normalized to the ribosomal protein
S18 and miRNA to the small RNA, U6. Agilent microRNA microarray
[G4471A-021828] hybridizedwith labeled RNA, extracted from tracheal
cartilage rings. The full proﬁle is provided in supplementary Table 1.
Assessment of direct miRNA-Snail1 3′UTR interactions
miRNA vectors for miR-30, miR-125b or miR-7 (Control), were gen-
erously given byReuven Agami. Thewholemouse Snail1 3′UTR (728nt;
NM_011427) was subcloned into a psiCHECK-2 Vector (Promega) and
transfected into HEK293T cells using JetPeiTM reagent (Polyplus), to-
gether with miRNA vectors. Fireﬂy and Renilla luciferase activity was
studied 48 h post-transfection, with dual luciferase assay (Promega).
miRNA knockdown
ATDC5 cells were cultured in differentiation medium (DMEM/F12
1:1(vol/vol), with 5% (vol/vol) fetal calf serum, 1% (vol/vol) PSG and
10 μg/ml ITS (Sigma)). 2′-O-methyl miRNA inhibitors against miR-
30a/c, mir-125b or miR-7 (irrelevant control) had been purchased
from Qiagen and transfected with HiPerFectTM (Qiagen) to ATDC5cells, and RNA was extracted with TRI reagent (MRC) at multiple
time points.
Snail1 over-expression in primary tracheal chondrocytes
Themouse Snail1 cDNAwas cloned into an adenoviral vector that har-
bors a CMV promoter and an IRES GFP detection cassette. Tracheae were
dissected from threeweek oldmice, incubated in 0.25% trypsin 2×15′. In-
dividual rings were manually teased, transferred into Hyaluronidase
(0.5 mg/ml; Sigma) PSG (2% vol/vol in DMEM) for 30′; 37°c and then
into Collagenase type V (1 mg/ml; Sigma) PSG (2% vol/vol in DMEM)
for 15′. Next, tracheal rings were transferred into a fresh Collagenase
V/PSG solution and aggressively agitated until completely dissociating
into single cells. Primary chondrocyteswere cultured in DMEMcontain-
ing fetal calf serum (10% vol/vol) and PSG (2% vol/vol in DMEM). Prima-
ry tracheal chondrocyteswere infectedwith the pCMV-Snail1-IRES-GFP
virus 12 h after culturing.
Results
Dicer1 deﬁciency in the tracheal chondrocytes leads to respiratory failure
at birth
To investigate the physiological role of miRNA activity in tracheal
rings, we crossed a Dicer1 conditional allele (Harfe et al., 2005) to a
transgene expressing Cre recombinase under the control of the Col2a1
promoter. This resulted in Dicer1 knockout and in repression of miRNA
maturation, speciﬁcally in chondrocytes (Figure S1A). Approximately
85% of the Col2a1-Cre:Dicerﬂ/ﬂ mice (named later ‘Col2DCRmut’) died
as neonates (early after birth), whilst Col2a1-Cre;Dicer1ﬂ/+ littermates
(‘controls’) seems to be phenotypically normal. Surviving Col2a1-Cre:
Dicerﬂ/ﬂ mice died before weaning and had signiﬁcant growth retarda-
tion relative to littermate controls as previously described in (Kobayashi
et al., 2008). In addition, E18.5 Col2a1-Cre:Dicerﬂ/ﬂ exhibited dentalmal-
occlusion, fenestrated skull vault cartilage, and malformed transverse
processes of lumbar vertebrae (Figure S2A,B).
Post mortem exploration revealed that col2DCRmut lungs failed to
inﬂate and that the alveoli did not ﬁll with air (Fig. 1A,B). This is con-
sistent with the apparent cyanosis of col2DCRmut pups. Since Dicer1
was conditionally deleted only in cartilaginous tissues, we further
evaluated whether defects in the rib cage and trachea may play a
role in the ventilation defect. Whole-mount alcian-blue/alizarin-red
examination revealed only minute changes in the rib cage (Fig. 1C), but
the tracheal ring and larynx cartilage staining was drastically reduced
(Fig. 1D). Thus, col2DCRmut newborns manifest tracheomalacia — a
condition characterized by ﬂaccidity of the tracheal support cartilage,
which leads to tracheal collapse. Conceivably, the defect in the quantity
or quality of the extracellular matrix is the reason for the observed neo-
natal asphyxia.
Partial chondrocyte differentiation and normal tracheal ring morphogenesis
in the Dicer1 mutants
To reveal the tissue composition of the Dicer1 mutant tracheae, we
crossed a ﬂuorescent genetic fate tracer (Giel-Moloney et al., 2007)
onto the genetic background of the col2DCRmut mice. In the resultant
col2DCRmut;R26R mice, cells in which recombination occurred, lose
Dicer1 activity and are additionally labeled with YFP. This analysis
revealed that chondrocytes are indeed present in the col2DCRmut tra-
chea. Furthermore, the tracheal cartilage is properly patterned into
multiple semi-lunar structures in both col2DCRmut and in Col2a1-Cre;
Dicer1ﬂx/+;R26R controls (Fig. 1E). While Dicer1 knockout has been
shown to initiate apoptosis in many cell types, loss of Dicer1 function
in chondrocyte was not reported to cause apoptosis (Kobayashi et al.,
2008). Consistently, we did not identify signs of programmed cell
death by searching for nuclear pyknosis or by performing a TUNEL assay.
Fig. 1. Tracheomalacia and disinﬂated alveoli in Col2DCRmut mice. Hematoxylin and Eosin analysis of thoracic transverse section of P1WT and Col2DCRmut (A,A’ bar=1 mm). Disinﬂated
alveoli observed on higher magniﬁcation of the same slides (B,B’,). Alcain blue/Alizarin red staining, reveals normally patterned rib cage in bothWT and Col2DCRmut (C,C’).Whole larynx
and trachea Alcian blue staining reveals poor deposition of ECM in Col2DCRmut tracheal rings and larynx relative to control (D,D’ arrow heads pointing to reduced matrix areas). Genetic
fate tracing of the Col2a1 lineage by a conditional Rosa26 YFP reporter exempliﬁes the normal morphogenesis of Col2DCRmut tracheal rings and larynx (E,E’).
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Col2DCRmut chondrocytes do not properly deposit ECM as required
and therefore poorly stainwith alcian-blue. To understand this phenotype
better, we evaluated the expression levels of Col2a1 and Aggrecan, twoFig. 2. Col2a1 and Aggrecan mRNA levels are lower, while Sox family transcription factors
antisense RNA probes for Col2a1 (A,A’), Aggrecan (B,B’) and Sox9 (C,C’). qPCR analysis of
Sox5 and Sox6 (E). Pooled tracheal ring RNA of 8 individual embryos; three repeats per geimportant matrix proteins in the tracheal cartilage. The in situ detection
of Col2a1 mRNA revealed reduced expression relative to controls and
was similarly quantiﬁed by qPCR (Fig. 2A,D). Aggrecan mRNA levels,
were also downregulated in col2DCRmut tracheal rings (Fig. 2B,D). Direct
evaluation of mRNA encoding for primary ECM proteins, brings us toare normally expressed in Col2DCRmut. Tracheal section in situ hybridization obtaining
Col2a1 and Aggrecan (D) and the mRNA encoding for the transcription factors Sox9,
notype. *=P valueb0.05.
Fig. 3. Snail1 is de-repressed in Col2DCRmut tracheae and is able to represses Col2a1 and Aggrecan expression in primary tracheal chondrocytes. qPCR analysis of potential repressors of
Col2a1 and Aggrecan transcription, preformed on RNA isolated from tracheal rings. Snail1 is speciﬁcally and signiﬁcantly upregulated. Pooled RNA sample from 8 Col2DCRmut tracheae
relative to controls. (A) Section in situ hybridization of tracheae with antisense RNA probes for Snail1 (B,B’). A representative immunoﬂuorescent micrograph from a BrdU incorporation
study of E18.5 Col2DCRmut andWT trachea (C,C’). BrdU-red, nuclei-blue. Cartilaginous rings demarcated by dashed lines. Bar graph quantiﬁcation of the number of BrdU-positive tracheal
chondrocytes (D; 500 cells/individual animal; n=3,3). qPCR analysis of P21 mRNA levels in RNA isolated from tracheal rings (E; n=3,3). Overexpression of Snail1 in primary tracheal
chondrocytes quantiﬁed by western-blot analysis relative to a control virus expressing GFP (F). qPCR analysis of Col2a1, Aggrecan and Sox9 mRNA in primary tracheal chondrocytes
infected with an adenoviral vector expressing GFP (gray) or Snail1 (black). (G; n=3,3). *=P valueb0.05.
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Col2a1 and Aggrecan expression in Col2DCRmut mice.
To examine the basic differentiation properties of the mutant
Col2DCRmut tracheal chondrocytes, we performed RNA in-situ hybridi-
zation for Sox9, the chief transcription factor in chondrocyte differenti-
ation. Sox9 was unchanged in col2DCRmut tracheal chondrocytes
relative to controls (Fig. 2C,E). Furthermore, the qPCR analysis of Sox9
and its two transcriptional co-activators Sox5 and Sox6, was within
the normal expression spectrum (Fig. 2E). We conclude from this
study that the core transcriptional machinery engaged in chondrogen-
esis is properly maintained in Col2DCRmut tracheal chondrocytes.
Why is Col2a1 and Aggrecan transcription downregulated in chon-
drocytes that express the three principle Sox transcriptional activators?
One potential reasonmay be because of abnormal upregulation of tran-
scriptional repressors in col2DCRmut tracheal chondrocytes. We there-
fore quantiﬁed the expression levels of a reported set of repressors of
Col2a1 or Aggrecan by qPCR, including Spen/Mint, Egr1, Snail1 (Snai1)
and Slug (Snai2) (Seki et al., 2003; Tan et al., 2003; Yang et al., 2005).
Runx2, a transcription factor that promotes chondrocyte hypertrophy
(Takeda et al., 2001) was also considered. The mRNA levels of Snail1
were upregulated in Col2DCRmut tracheal chondrocytes, while themRNA levels of other candidate inhibitors were not signiﬁcantly chan-
ged (Fig. 3A). Once Snail1 upregulation was substantiated by mRNA
in-situ hybridization (Fig. 3B), we considered it a prime candidate re-
pressor of Col2a1 and Aggrecan in col2DCRmut tracheal chondrocytes.
Intriguingly, misexpression of a Snail1 transgene in growth plate
chondrocytes induces Sox9 expression, represses chondrocyte prolif-
eration and upregulates the transcription of P21 (de Frutos et al.,
2007). Therefore, if Snail1 upregulation is functionally important for
the observed phenotype in Col2DCRmut tracheal rings, then P21 levels
should be upregulated and proliferation should be decreased relative
to wild type chondrocytes. When we performed BrdU incorporation
analysis of E17.5 tracheal chondrocytes, we identiﬁed a 20% reduction
in Col2DCRmut tracheal chondrocyte proliferation relative to controls
(Fig. 3C,D). At the same time, the expression levels of P21 were signif-
icantly upregulated in the mutants (Fig. 3E). These observations sup-
port functional upregulation of Snail1 in Col2DCRmut tracheae.
In order to verify that Snail1 can indeed negatively regulate Col2a1
and Aggrecan synthesis in the trachea, we isolated primary tracheal
chondrocytes and infected them with an adenoviral vector misexpres-
sing Snail1. Snail1was overexpressed four fold relative to control, in levels
comparable with Snail1 expression in Col2DCRmut tracheal chondrocytes.
Fig. 4. Col2a1 and Aggrecan mRNA levels are downregulated and Snail1 is up-regulated in the neurocranium cartilage of Col2DCRmut. qPCR analysis of Col2a1, Aggrecan, Sox9 and
Snail1 preformed on RNA isolated from neurocranium cartilage, suggest that Col2a1 and Aggrecan levels are reduced, Snail1 levels are up-regulated without change in Sox9 levels
(A) n=3 with 3 technical repeats, *=P valueb0.05. Whole mount alcian-blue/Alizarin-red staining of WT (B) and Col2DCRmut (B’) cranium. Section alcian-blue/nuclear fast-red
staining of WT (C) and Col2DCRmut (C’) interparietal cartilage. Sox9 RNA in-situ hybridization on WT (D) and Col2DCRmut (D’) interparietal cartilage. Col2a1 RNA in-situ hybridi-
zation on WT (E) and Col2DCRmut (E’) interparietal cartilage. Note diminished Col2a1 signal right to the dashed line, where corresponding Sox9 expression in adjacent section
(D’) is continuous.
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regulation of Col2a1 andAggrecan expressionobserved in the col2DCRmut
trachea (Fig. 3F,G). Taken together, these data indicate that the upregula-
tion of Snail1 effectively reduces Col2a1 andAggrecan transcription and is
likely responsible also for the reduced proliferation observed in the
col2DCRmut trachea.
We next studied additional Col2DCRmut cartilaginous tissues includ-
ing the neurocranium that was also found to be poorly stained by alcian
blue (Fig. 4B,B’). qPCR analysis revealed that Col2a1 and Aggrecan levels
are downregulated while Snail1 levels are increased (Fig. 4A). Section
analysis of the interparietal neurocranium, revealed reduced matrix
staining and fenestrated cartilages (Fig. 4B,B’ and 4 C,C’). Furthermore,
Sox9 and Col2a1 RNA in situ hybridization on adjacent interparietal
neurocranium sections, revealed speciﬁc tissue compartments, wherein
Sox9 is normally detected, yet Col2a1 mRNA is not expressed (Fig. 4D,
D’, and 4E,E’).
The specialized articular cartilage of the joint also produces Col2a1. In
additional, it expresses a unique articular isoform, namely Col2b (Kahn
et al., 2009; Nalin et al., 1995). Our analysis did not reveal any change
in the expression of Col2a1, Col2b, Snail1 or Sox9 in Col2DCRmut articular
cartilage, relative to control (Figure S4).We conclude thatmiRNA are es-
sential for the proper expression of matrix proteins in cartilages but this
phenotype is readily evident in the tracheal and cranial cartilage tissues
and was not equally-detected in the articular or rib cartilages.
miR-30a/c and miR-125b are regulators of Snail1
As Dicer1 deletion removes the entire set ofmiRNAs, we next sought
the speciﬁc miRNA genes that are responsible for the de-regulation of
Col2a1 and Aggrecan expression upstream of Snail1. In order to narrowdown the possiblemiRNA candidateswe took a bioinformatics approach
obtaining TargetScan (Lewis et al., 2005) to identify miRNA binding sites
(seed-matches) on Snail1 3′UTR. We found potential seed matches on
the 3′UTR of Snail1 for miR-30, miR-125b and miR-153 (Fig. 5A).
To further ﬁlter potential miRNA candidates upstream of Snail1,
we have screened a miRNA expression array (Agilent) with RNA de-
rived from isolated E18.5 tracheal chondrocytes (Fig. 5B). Known car-
tilage miRNAs such as mir-140, mir-199 andmir-214 (Lee et al., 2009;
Lin et al., 2009; Miyaki et al., 2010; Nicolas et al., 2008; Tuddenham et
al., 2006; Watanabe et al., 2008) are highly expressed in the tracheal
ring cartilage. The detailed list of expressed miRNA may be found at
Table S1.
Based on this global analysis, we identiﬁed three miRNA genes,
which are both highly expressed in tracheal chondrocytes and also po-
tentially bind to complementary sequences on the Snail1 3′UTR, name-
ly, miR-30a, miR-30c and miR-125b. A fourth miRNA, miR-153 that is
predicted to target the Snail1 mRNA, is not expressed in tracheal chon-
drocytes and therefore was omitted from further evaluation.
In order to functionally assess potential direct interactions of the can-
didate miRNAs with the predicted regulatory sequences on the Snail1
mRNA, we cloned the Snail1 3′UTR into a psiCHECK-2TM vector, that is
additionally expressing a Renilla luciferase for internal normalization
of transfection efﬁciency. HEK 293T Cells were then co-transfected
with the luciferase-Snail1 3′UTR reporter alone, or in addition to mir-
30a or mir-125b expression vectors. The relative luciferase activity in
the presence of potential targetingmiRNAswas quantiﬁed. This analysis
revealed that miR-30 represses the expression of the luciferase reporter
by 60% andmiR-125 dampens the reporter expression by 30% (Fig. 5C,D).
The inhibition could not be gained by the expression of miR-7, an irrele-
vant miRNA. Furthermore, inhibition was completely abrogated when
Fig. 5. Snail1 is a target of miR-30a/c and miR-125b in tracheal chondrocytes. The Snail1 3′UTR harbors conserved binding sites for mir-125b, mir-153, and mir-30 (A). RNA
extracted from tracheal cartilage rings of wild type mice, hybridized onto an Agilent miRNA expression array. The speciﬁc miRNA proﬁle of E18 tracheal chondrocytes is presented
along the X-axis, from highly expressed miRNA genes (left) to low expressed genes (right) on a Log2 scale in arbitrary units. miR-125b miR-30a and miR-30c species are annotated
by an arrow and a triangle (B). A scheme of the luciferase-Snail1-3′UTR vectors, harboring the Snail1 3′UTR; mu-125 and mu-30 are reporter with mutant binding sites for miR-125
or miR-30, respectively (C). A bar graph of normalized luciferase activity in HEK293T cells, transfected with a luciferase-Snail1-3′UTR and an expression vector for an irrelevant
miRNA (miR-7), miR-30, miR-125, or both miR-30/miR-125 together (n=6, in two technical duplicates).
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(Fig. 5C,D). We conclude that Snail1 is regulated by miR-125 and miR-
30 through two conserved bona-ﬁde sites on its 3′UTR.
Speciﬁc miR-30/125b knockdown de-represses Snail1 and downregulates
Aggrecan and Col2a1 expression
Snail1 was shown to impair Collagen 2a1 and Aggrecan expression
in ATDC5 cells (Seki et al., 2003). To functionally link miR-125b and
miR-30a/c to Snail1, we knocked-down these miRNAs, obtaining anti-
sense oligos. We ﬁrst transfected speciﬁc miR-125b/30a/c inhibitors,
along with the Snail1 3′UTR reporter. The luciferase activity from the
Snail1 reporter was upregulated by transfectingmiRNA inhibitors, rela-
tive to mock transfected ATDC5 cells (Fig. 6A). Next, we monitored the
expression of endogenous Snail1, which was upregulated when miR-
125b/30a/c inhibitors were introduced to ATDC5 cells. Sox9 levels
were not attenuated under these conditions. A few days later, the ex-
pression of Col2a1 and Aggrecanwas downregulated, relative to control
(Fig. 6B). These data suggest Snail1 as a key target of miR-125b/30a/c.
To see if Snail1 is indeed a primary target of miR-125b/30a/c in chondro-
cytes, we designed a combined loss-of-function experiment, wherein we
knocked-down simultaneouslymiR-125b/30a/c and Snail1. Snail1 knock-
down in the background of miR-125b/30a/c inhibition restored Colla-
gen 2a1 and Aggrecan expression levels (Fig. 6C). Together, these dataprovide experimental evidence for miR-125b/30a/c-based repression
of Snail1 that is needed for normal expression of Col2a1 and Aggrecan
in tracheal chondrocytes.
Discussion
Loss of miRNA activity in the tracheal cartilage manifests with tra-
cheomalacia — a condition characterized by ﬂaccidity of the tracheal
support cartilage, which leads to tracheal collapse. Airway collapse
in Col2DCRmut pups leads to lung disinﬂation and lethal asphyxia.
Loss of structural cartilage is conceivably the reason for the
Col2DCRmut tracheomalacia. Such pathology could result for example
from massive chondrocyte death. However, lineage tracing revealed
apparently-normal morphogenesis of semi-lunar rings in the col2DCRmut
trachea and apoptosis was not detected.
Surprisingly, col2DCRmut chondrocytes express the transcription
factors Sox9, Sox5 and Sox6 that set chondrocyte differentiation in
motion and are also required for transcription of ECM proteins such
as Col2a1 and Aggrecan. This suggests that col2DCRmut chondrocytes
properly initiate their differentiation program (Fig. 2). However, the
steps that are required for acquisition of a fully functional chondro-
cyte state are blocked by the loss of miRNA activity. We provide evi-
dence that chondrocyte differentiation and function is hampered, at
least in certain cartilage tissues, because of improper expression of the
Fig. 6. miR-125b and miR-30 control Col2a1 and Aggrecan synthesis through Snail1 expression and reduces. ATDC5 cells were transfected with 2′-O-methyl antisense inhibitor
against miR-125b and miR-30. The expression of a luciferase-Snail1-3′UTR reporter is speciﬁcally upregulated by the miR-125b/30 inhibitors (A). The expression of Col2a1,
Aggrecan, Snail1 and Sox9 mRNA over several days after transfection with miR-125b/30a/c inhibitors, relative to control (B). The expression of Col2a1, Aggrecan, Snail1 and
Sox9 mRNA over several days after transfection with siRNA against Snail1 and miR-125b/30 inhibitors, relative to miR-125b/30a/c inhibitors alone (C). Data in (B,C) is
normalized to the expression of GAPDH and of S18 RNA. (n=3; three technical repeats) *=P valueb0.05. A model for miR-125/miR-30 –dependant repression of Snail1 is the
normal developing tracheal cartilage (D). Loss of miRNA activity in Col2DCRmut trachea or in chondrocytes transfected with miR-125b/30a/c inhibitors, de-represses Snail1 and
consequently represses the transcription of Col2a1 and Aggrecan (E).
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is necessary in the growth plate (de Frutos et al., 2007; Hong et al., 2009;
Seki et al., 2003). The particular developmental programof tracheal chon-
drocytes requires permanent expression of Col2a1 and ectopic FGF
signaling was previously shown to cause mal-genesis of the trachea
(Eswarakumar et al., 2004). Overexpression of Snail1, the effector of
FGF signaling, downregulates Col2a1 synthesis, represses cell prolifer-
ation and upregulates the cyclin-dependent kinase inhibitor P21
(de Frutos et al., 2007).
We have observed Snail1 upregulation and its typical downstream
sequella in tracheal and neurocranial chondrocytes of the col2DCRmut.
This is particularly intriguing since neurocranial chondrocytes are neural-
crest descendants, rooting from the ectoderm. Thus, like with Sox9 and
other transcription factors, the importance of miRNAs is commonly
shared by chondrocytes of different lineages. However, in some other
case, e.g., the articular cartilage, loss of miRNA activity did not seems
to result in similar molecular and functional changes, suggesting tis-
sue-speciﬁc functions of miRNAs. Taken together these data aresuggesting that at least in some cartilages miRNAs function represses
FGF/Snail1 signaling, thus supporting proper secretion of matrix
proteins.
miR-125b and miR-30 family members are highly expressed in tra-
cheal chondrocytes and regulate Snail1 mRNA through evolutionarily
conserved binding sites. In fact, an exceptionally-long paired-recognition
sequence makes miR-30 particularly potent in repressing Snail1 ex-
pression. Indeed, in cultured chondrocytes, miR-125 and miR-30
knock-down by speciﬁc inhibitors resulted in upregulated expres-
sion of Snail1. Consistently, Snail1 downstream targets, Col2a1 and
Aggrecan were repressed. Furthermore, since the compound knock-
down of Snail1 and mir-125/30a/c restored Col2a1 and Aggrecan ex-
pression we argue that Snail1 is a primary target downstream of
miR-125b/30a/c. Taken together, miR-125b/30a/c speciﬁcally func-
tion as positive regulators of chondrocyte differentiation by repres-
sing harmful Snail1 expression (Fig. 6 D,E model). Nonetheless, it is
likely that additional miRNAs play regulatory roles controlling chon-
drocyte differentiation.
65B. Gradus et al. / Developmental Biology 360 (2011) 58–65In summary, Snail1 is an effector of FGF signaling that is important in
growth plate cartilage development but is repressed in the trachea to
enable the differentiation of chondrocytes of this life-supporting
organ. In the intact developing trachea, one important role of miR-30
and miR-125b is to keep Snail1 at low levels and to allow for full
functional differentiation of Col2a1 expressing chondrocytes. Loss of
this miR-125/30-based safeguardmechanism against unwanted activa-
tion of Snail1, uncovers the unique nature of the cartilages such as the
trachea that depend on miRNA to permanently maintain Collagen 2a1
and Aggrecan expression.
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